Searched for
DOLUTEGRAVIR
Lupin gets USFDA nod for generic HIV drugLupin has received tentative approval from the USFDA to market a generic HIV drug in the US under PEPFAR. The drug, made at Lupin's Nagpur ...- Smallcap pharma stock jumps over 11% as arm receives tentative USFDA approval for HIV drug DolutegravirThe company has 260 cumulative ANDA filings (including the recently acquired portfolio from Endo at Chestnut Ridge) with the USFDA, of whic...
- Stocks in news: Infosys, United Spirits, Gufic Biosciences, Alkem Labs, Bharat ForgeFollowing an order passed on applicability of GST rate on royalty income, the company has filed an appeal before Joint Commissioner Of Comm...
- Strides Pharma arm gets USFDA tentative nod for generic HIV treatment drugStrides Pharma Global, a subsidiary of Strides Pharma Science, has received tentative approval from the US FDA for its generic Dolutegravir...
- Prices of drugs going off patent to be slashed to 50%In case of Fixed dose combinations (FDC) where one component is going off patent the ceiling price will be revised by reducing the present ...
- Lupin gets tentative USFDA nod for Dolutegravir, Emtricitabine and Tenofovir Alafenamide tabletsThe tentative approval by the United States Food and Drug Administration (USFDA) has been granted under the President's emergency plan for ...
- Anti-diabetes drugs and patented antivirals to get cheaper, NLEM notifiedFor the first time, patented drugs like anti-TB bedaquiline and delamanid, anti-HIV Dolutegravir and anti-hepatitis C daclatasvir are also ...
- Getting patented meds on NLEM list an uphill battle says committee memberAs many as 34 new drugs were added and 26 dropped from an updated list of essential medicines.For the first time patented drugs like anti-T...
- Diabetes, patented TB, HIV drugs enter essential listPopular anti-diabetes drug teneligliptin, insulin glargine injection, Common antibiotics like meropenem, Cefuroxime have been included in t...
- Adequate stock of antiretroviral drugs for 95% 'People Living with HIV' in India: SourcesThere is no reported stock out for any antiretroviral (ARV) drugs at the state level and fresh supply orders for procurement of the next lo...
- Lupin gets USFDA nod for HIV drug under PEPFARLupin got a green signal from the US health regulator to sell HIV drug in the American market. The product that has received a nod under US...
- Buy Laurus Labs, target Rs 535: HDFC SecuritiesBuy Laurus Labs at a price target of Rs 535.
- Buy Laurus Labs, target Rs 470: Motilal Oswal SecuritiesBuy Laurus Labs at a price target of Rs 470.
- Aurobindo Pharma gets nod from South African health authority for HIV drugThe approval further strengthens the company's HIV product basket in South Africa, which has the potential to improve the lives of millions...
- Top stocks in focus on Tuesday, 22 August 2017Here is a list of top stocks that are likely to be in focus in today's trading session.
- Aurobindo Pharma gets USFDA nod for anti-HIV drugAurobindo Pharma has received tentative approval from the USFDA for dolutegravir, lamivudine and tenofovir disoproxil fumarate tablets, use...
- Activists cry foul over new HIV drug monopolyOnly one Indian drug maker, Emcure, will be allowed to sell the medicine in the Indian private market, because of a licensing agreement wit...
- Outperform Aurobindo Pharma., target Rs 910: Credit SuisseAurobindo Pharma added $450 mn in market cap on Dolutegravir (DTG) approval.
- Sensex rallies 266 pts; Nifty50 holds above 8,850The Sensex rose 0.93 per cent to 28,773.13, its highest close since September 9.
- Cipla, Aurobindo, Emcure to supply HIV drugs for UN-backed programmeAurobindo Pharma Chief Executive Officer said the new licence would help ensure the timely introduction of generic ATV in developing countr...
Load More
